PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds that carbon monoxide can help shrink tumors and amplify effectiveness of chemotherapy

Therapeutic benefits appear linked to cell's energy status; used in combination with chemo, CO helps spare healthy tissue

2013-12-04
(Press-News.org) Contact information: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Study finds that carbon monoxide can help shrink tumors and amplify effectiveness of chemotherapy Therapeutic benefits appear linked to cell's energy status; used in combination with chemo, CO helps spare healthy tissue BOSTON -- In recent years, research has suggested that carbon monoxide, the highly toxic gas emitted from auto exhausts and faulty heating systems, can be used to treat certain inflammatory medical conditions. Now a study led by a research team at Beth Israel Deaconess Medical Center (BIDMC) shows for the first time that carbon monoxide may also have a role to play in treating cancer.

The surprising new findings, described in the December issue of the journal Cancer Research, show that in cell culture and animal models carbon monoxide (CO) can both prevent tumor growth in prostate and lung cancers and can amplify the effectiveness of chemotherapy 1,000-fold – while sparing noncancerous tissue from chemo's sometimes debilitating side effects.

"We found that in small, carefully controlled doses, CO not only mimicked the effects of chemotherapy agents by blocking proliferation of cancer cells, but also amplified the toxic effects of the chemotherapy drugs doxorubicin and camptothecin to accelerate cancer cell death," says senior author Leo Otterbein, PhD, an investigator in the Transplant Institute in BIDMC's Department of Surgery and Associate Professor of Surgery at Harvard Medical School. "Importantly and rather unique is that CO also helped to protect normal tissue from chemotherapy, which is an unfortunate side effect of the treatments."

The new discovery appears to hinge on CO's ability to switch the metabolic state of cancer cells so that tumors essentially work themselves to death. "There are fundamental differences in the metabolism of normal cells and cancer cells," explains Otterbein. "Cancer cells are able to alter their metabolism in processing sugars and other energy sources, which enable them to rapidly proliferate and spread. This shift in metabolism is known as the Warburg Effect. Our findings indicate that CO essentially induces an 'anti-Warburg' effect, rapidly fueling cancer cell bioenergetics by compelling the cancer cell to increase respiration, which ultimately results in metabolic exhaustion."

The body naturally generates CO under stress through the increased expression of the gene heme oxygenase-1 (HO-1 Hmox1), a cytoprotective stress response gene that generates CO as it catabolizes heme, an essential component of many proteins such as hemoglobin. The increase in HO-1 has been shown to occur under numerous and diverse stressors, such as inflammation, trauma and even tissue repair. Tumors, however, are often absent this capability because HO has become inactive and unable to generate sufficient levels of CO. In this new paper, Otterbein and first author Barbara Wegiel, PhD, also an investigator in BIDMC's Transplant Institute, wanted to find out if a tumor's inability to produce CO naturally was what was fueling cancer growth.

"If A plus B equals C, then, we reasoned, if you administered carbon monoxide to tumors, you would reestablish a tumor cell's ability to regulate its cell growth, and so, too, slow that growth," says Otterbein.

The authors first conducted a detailed analysis of more than 500 tumor samples from prostate cancer patients. "Through these biopsies, we confirmed expression of HO-1," explains Wegiel, who is also an Assistant Professor of Surgery at HMS. "But we found that HO-1 in the tumor was simply not active. It was not producing sufficient amounts of CO, and we thought this was contributing to altered cell growth and malignancy."

This finding led to their hypothesis that HO-1, through its ability to generate CO, was regulating the growth of cancer cells, a discovery that had been observed and well described in other cell types. To test this hypothesis, mice with established tumors were started on a regimen of inhaled CO of one hour per day at a safe, low concentration, equal to that approved for use in humans in ongoing clinical trials. Tumor size was measured daily over four to six weeks. In the cancer cell CULTURES, metabolic activity in the mitochondria – the cells' energy-generating organelle-- were measured using biochemical markers as well as imaging techniques.

"We found that exposure to CO sensitized the prostate cancer cells -- but not the normal cells -- to chemotherapy," explains Otterbein. "CO targeted mitochondria activity in cancer cells as evidenced by higher oxygen consumption, free radical generation and, ultimately, mitochondrial collapse.

"Collectively, our findings indicated that CO induces an anti-Warburg effect by rapidly fueling cancer cell bioenergetics, ultimately resulting in metabolic exhaustion," he adds. Importantly, CO protected normal cells from DNA damage generated by cytotoxic agents, in part by reducing oxygen consumption and eliciting a hibernation-like state in these cells. "Essentially, these normal cells entered growth arrest and slowed their metabolic rate, in marked contrast to the cancer cells, which continued to consume oxygen at a rate that ultimately led to their demise."

While the authors note that more research will be needed to confirm these findings, they provide a promising new direction for cancer treatment.

"Chemotherapy remains the first-line therapy for many types of cancer, including breast and lung cancers," notes study coauthor and BIDMC Chief Academic Officer Vikas Sukhatme, MD, PhD. "But chemotherapy's debilitating side effects and limited effectiveness are well known. This new finding opens up the possibility of new therapeutic interventions that take advantage of powerful chemotherapy drugs, perhaps making them even more potent while simultaneously limiting their terrible side effects and damage to normal cells and tissues. There are ongoing innovative methodologies being designed and tested to deliver CO directly to the tumor site, which might obviate the need for additional drugs. Indeed, small molecules are being designed that can carry CO as a cargo and deliver it in a tissue-specific manner."

### This work was supported by grants from the National Institutes of Health (HL-071797; HL-076167, as well as support from AHA, the Julie Henry Fund, the British Heart Foundation and Medical Research Council.

In addition to Otterbein, Wegiel and Sukhatme, study coauthors include BIDMC investigators David Gallo, Eva Csizmadia, Clair Harris, Pankaj Seth and Pier Paolo Pandolfi and investigators John Belcher, Gregory Vercellotti, Leszek Helczynski, Anders Bjartell, Jenny Liao Persson, Nuno Penacho and Asif Ahmed.

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and currently ranks third in National Institutes of Health funding among independent hospitals nationwide.

BIDMC has a network of community partners that includes Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Health Care, Commonwealth Hematology-Oncology, Beth Israel Deaconess HealthCare, Community Care Alliance, and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of the Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.org.


ELSE PRESS RELEASES FROM THIS DATE:

The first decade: Team reports on US trials of bioenergy grasses

2013-12-04
The first decade: Team reports on US trials of bioenergy grasses CHAMPAIGN, Ill. — The first long-term U.S. field trials of Miscanthus x giganteus, a towering perennial grass used in bioenergy production, reveal ...

AGU journal highlights -- Dec. 4, 2013

2013-12-04
AGU journal highlights -- Dec. 4, 2013 The following highlights summarize research papers that have been recently published in Geochemistry, Geophysics, Geosystems (G3), Geophysical Research Letters (GRL), and Journal of Geophysical Research-Atmospheres (JGR-D). In ...

Death of an adult son increases depressive symptoms in mothers, but not fathers

2013-12-04
Death of an adult son increases depressive symptoms in mothers, but not fathers PRINCETON, NJ—Mothers – but not fathers – exhibited symptoms of depression and experienced declines in overall health after ...

New target identified for preventing bone destruction in diseases such as arthritis and cancer

2013-12-04
New target identified for preventing bone destruction in diseases such as arthritis and cancer VIDEO: The skeleton is constantly being remodelled by the breakdown ...

Malaria treatment could improve in children

2013-12-04
Malaria treatment could improve in children An analysis of patients from across the malaria endemic world suggests that a key antimalarial treatment could be improved by better dosing in young children Antimalarial drug resistance has hampered malaria control programs ...

Many trial results in ClinicalTrials.gov not published

2013-12-04
Many trial results in ClinicalTrials.gov not published Half of trials with results posted in ClinicalTrials.gov database have not been published in a journal, and for some that have, the database contains more information The trial registry ClinicalTrials.gov, which permits ...

Signalers vs. strong silent types: Sparrows exude personalities during fights

2013-12-04
Signalers vs. strong silent types: Sparrows exude personalities during fights Like humans, some song sparrows are more effusive than others, at least when it comes to defending their territories. New findings from the University of Washington show that consistent ...

Improving patient continuity of care in hospitals linked with reduction in medical errors

2013-12-04
Improving patient continuity of care in hospitals linked with reduction in medical errors Implementation of a multifaceted program to improve patient handoffs (change in staff caring for a patient) among physicians-in-training residents at a children's ...

Diversity initiatives do not increase representation of minorities on medical school faculty

2013-12-04
Diversity initiatives do not increase representation of minorities on medical school faculty From 2000 to 2010, the presence of a minority faculty development program at U.S. medical schools was not associated with greater underrepresented minority faculty representation, ...

Study examines incidence, trend of substance use disorder among medical residents

2013-12-04
Study examines incidence, trend of substance use disorder among medical residents Among anesthesiology residents entering primary training from 1975 to 2009, 0.86 percent had a confirmed substance use disorder during training, with the incidence of this disorder ...

LAST 30 PRESS RELEASES:

Ground breaking advances in construction robotics in extreme environments unveiled in review

New strategies to enhance chiral optical signals unveiled

Cambridge research uncovers powerful virtual reality treatment for speech anxiety

2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

[Press-News.org] Study finds that carbon monoxide can help shrink tumors and amplify effectiveness of chemotherapy
Therapeutic benefits appear linked to cell's energy status; used in combination with chemo, CO helps spare healthy tissue